LPS and HIV gp120 modulate monocyte/macrophage CYP27B1 and CYP24A1 expression leading to vitamin D consumption and hypovitaminosis D in HIV-infected individuals

European Review for Medical and Pharmacological Sciences

Volumn 17, Issue 14, 2013, Pages 1938-1950

  Pinzone, M R ^a   Di Rosa, M ^a   Celesia, B M ^a   Condorelli, F ^b   Malaguarnera, M ^a   Madeddu, G ^c   Martellotta, F ^d   Castronuovo, D ^a   Gussio, M ^a   Coco, C ^a   Palermo, F ^a   Cosentino, S ^a   Cacopardo, B ^a   Nunnari, G ^a,e  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^c UNIVERSITY OF SASSARI   (Italy)

^d CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Gp 120; HIV infected patients; Lipopolysaccharide; Parathormone; Vitamin D deficiency; Vitamin D receptor

Indexed keywords

C REACTIVE PROTEIN; CYTOCHROME P450; CYTOCHROME P450 24A1; CYTOCHROME P450 27B1; GLYCOPROTEIN GP 120; LIPOPOLYSACCHARIDE; MESSENGER RNA; PARATHYROID HORMONE; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D RECEPTOR; 25 HYDROXYERGOCALCIFEROL; CALCIDIOL 1 MONOOXYGENASE; INTERLEUKIN 6; PRIMER DNA; STEROID MONOOXYGENASE; VITAMIN D 24 HYDROXYLASE; VITAMIN D 24-HYDROXYLASE;

ADULT; ARTICLE; BODY MASS; CATABOLISM; CHRONIC INFLAMMATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IN VITRO STUDY; ITALY; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PROTEIN EXPRESSION; SEX DIFFERENCE; VIRUS REPLICATION; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECT; ENZYMOLOGY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

25-HYDROXYVITAMIN D 2; 25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; ADULT; CELLS, CULTURED; DNA PRIMERS; FEMALE; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HUMANS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MIDDLE AGED; MONOCYTES; MULTIVARIATE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; STEROID HYDROXYLASES; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84884194135     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. BERRETTA M, CINELLI R, MARTELLOTTA F, SPINA M, VACCHER E, TIRELLI U. Therapeutic approaches to AIDS-related malignancies. Oncogene 2003; 22: 6646-6659.
2. NUNNARI G, OTERO M, DORNADULA G, VANELLA M, ZHANG H, FRANK I, POMERANTZ RJ. Residual HIV-1 disease in seminal cells of HIV-1-infected men on suppressive HAART: latency without on-going cellular infections. AIDS 2002; 16: 39-45.
3. NUNNARI G, GUSSIO M, PINZONE MR, MARTELLOTTA F, COSENTINO S, CACOPARDO B, CELESIA BM. Cryptococcal meningitis in an HIV-1-infected person: relapses or IRIS? Case report and review of the literature. Eur Rev Med Pharmacol Sci 2013; 17: 1555-1559.
4. NUNNARI G, SULLIVAN J, XU Y, NYIRJESY P, KULKOSKY J, CAVERT W, FRANK I, POMERANTZ RJ. HIV type 1 cervicovaginal reservoirs in the era of HAART. AIDS Res Hum Retroviruses 2005; 21: 714-718.
5. KULKOSKY J, BOUHAMDAN M, GEIST A, NUNNARI G, PHINNEY DG, POMERANTZ RJ. Pathogenesis of HIV-1 infection within bone marrow cells. Leuk Lymphoma 2000; 37: 497-515.
6. POMERANTZ RJ, NUNNARI G. HIV and GB virus C - can two viruses be better than one? N Engl J Med 2004; 350: 963-965.
7. DORNADULA G, NUNNARI G, VANELLA M, ROMAN J, BABINCHAK T, DE SIMONE J, STERN J, BRAFFMAN M, ZHANG H, POMERANTZ RJ. Human immunodeficiency virus type 1-infected persons with residual disease and virus reservoirs on suppressive highly active antiretroviral therapy can be stratified into relevant virologic and immunologic subgroups. J Infect Dis 2001; 183: 1682-1687.
8. OTERO M, NUNNARI G, LETO D, SULLIVAN J, WANG FX, FRANK I, XU Y, PATEL C, DORNADULA G, KULKOSKY J, POMERANTZ RJ. Peripheral blood Dendritic cells are not a major reservoir for HIV type 1 in infected individuals on virally suppressive HAART. AIDS Res Hum Retroviruses 2003; 19: 1097-1103.
9. NUNNARI G, ARGYRIS E, FANG J, MEHLMAN KE, POMERANTZ RJ, DANIEL R. Inhibition of HIV-1 replication by caffeine and caffeine-related methylxanthines. Virology 2005; 335: 177-184.
10. SMITH JA, NUNNARI G, PREUSS M, POMERANTZ RJ, DANIEL R. Pentoxifylline suppresses transduction by HIV-1-based vectors. Intervirology 2007; 50: 377-386.
11. PINZONE MR, CACOPARDO B, CONDORELLI F, DI ROSA M, NUNNARI G. Sirtuin-1 and HIV-1: An overview. Curr Drug Targets 2013; 14: 648-652.
12. WANG FX, XU Y, SULLIVAN J, SOUDER E, ARGYRIS EG, ACHEAMPONG EA, FISHER J, SIERRA M, THOMSON MM, NAJERA R, FRANK I, KULKOSKY J, POMERANTZ RJ, NUNNARI G. IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART. J Clin Invest 2005; 115: 128-137.
13. ZANET E, BERRETTA M, DI BENEDETTO F, TALAMINI R, BALLARIN R, NUNNARI G, BERRETTA S, RIDOLFO A, LLESHI A, ZANGHÍ A, CAPPELLANI A, TIRELLI U. Pancreatic cancer in HIV-positive patients: a clinical casecontrol study. Pancreas 2012; 41: 1331-1335.
14. BERRETTA M, GARLASSI E, CACOPARDO B, CAPPELLANI A, GUARALDI G, COCCHI S, DE PAOLI P, LLESHI A, IZZI I, TORRESIN A, DI GANGI P, PIETRANGELO A, FERRARI M, BEARZ A, BERRETTA S, NASTI G, DI BENEDETTO F, BALESTRERI L, TIRELLI U, VENTURA P. Hepatocellular carcinoma in HIV-infected patients: check early, treat hard. Oncologist 2011; 16: 1258-1269.
15. BERRETTA M, LLESHI A, CAPPELLANI A, BEARZ A, SPINA M, TALAMINI R, CACOPARDO B, NUNNARI G, MONTESARCHIO V, IZZI I, LANZAFAME M, NASTI G, BASILE F, BERRETTA S, FISICHELLA R, SCHIANTARELLI C, GARLASSI E, RIDOLFO A, GUELLA L, TIRELLI U. Oxaliplatin based chemotherapy and concomitant highly active antiretroviral therapy in the treatment of 24 patients with colorectal cancer and HIV infection. Curr HIV Res 2010; 8: 218-222.
16. BERRETTA M, CAPPELLANI A, DI BENEDETTO F, LLESHI A, TALAMINI R, CANZONIERI V, ZANET E, BEARZ A, NASTI G, LACCHIN T, BERRETTA S, FISICHELLA R, BALESTRERI L, TORRESIN A, IZZI I, ORTOLANI P, TIRELLI U. Clinical presentation and outcome of colorectal cancer in hivpositive patients: a clinical case-control study. Onkologie 2009; 32: 319-324.
17. BERRETTA M, ZANET E, BASILE F, RIDOLFO AL, DI BENEDETTO F, BEARZ A, BERRETTA S, NASTI G, TIRELLI U. HIV-positive patients with liver metastases from colorectal cancer deserve the same therapeutic approach as the general population. Onkologie 2010; 33: 203-204.
18. ZANET E, BERRETTA M, MARTELLOTTA F, CACOPARDO B, FISICHELLA R, TAVIO M, BERRETTA S, TIRELLI U. Anal cancer: focus on HIV-positive patients in the HAART era. Curr HIV Res 2011; 9: 70-81.
19. NUNNARI G, XU Y, ACHEAMPONG EA, FANG J, DANIEL R, ZHANG C, ZHANG H, MUKHTAR M, POMERANTZ RJ. Exogenous IL-7 induces Fas-mediated human neuronal apoptosis: potential effects during human immunodeficiency virus type 1 infection. J Neurovirol 2005; 11: 319-328.
20. NUNNARI G, POMERANTZ RJ. IL-7 as a potential therapy for HIV-1-infected individuals. Expert Opin Biol Ther 2005; 5: 1421-1426.
21. NUNNARI G, BERRETTA M, PINZONE MR, DI ROSA M, CAPPELLANI A, BERRETTA S, TIRELLI U, MALAGUARNERA M, SCHNELL JM, CACOPARDO B. Hepatocellular carcinoma in HIV positive patients. Eur Rev Med Pharmacol Sci 2012; 16: 1257-1270.
22. MARTELLOTTA F, BERRETTA M, CACOPARDO B, FISICHELLA R, SCHIOPPA O, ZANGHÍ A, SPARTÀ D, CAPPELLANI A, TALAMINI R, IZZI I, RIDOLFO A, TORRESIN A, FIORICA F, Tirelli U. Clinical presentation and outcome of squamous cell carcinoma of the anus in HIV-infected patients in the HAART-era: a GICAT experience. Eur Rev Med Pharmacol Sci 2012; 16: 1283-1291.
23. BERRETTA M, DI BENEDETTO F, DAL MASO L, CACOPARDO B, NASTI G, FACCHINI G, BEARZ A, SPINA M, GARLASSI E, DE RE V, FIORICA F, LLESHI A, TIRELLI U. Sorafenib for the treatment of unresectable hepatocellular carcinoma in HIV-positive patients. Anticancer Drugs 2013; 24: 212-218.
24. PINZONE MR, FIORICA F, DI ROSA M, MALAGUARNERA G, MALAGUARNERA L, CACOPARDO B, ZANGHÍ G, NUNNARI G. Non-AIDS-defining cancers among HIV-infected people. Eur Rev Med Pharmacol Sci 2012; 16: 1377-1388.
25. BEARZ A, VACCHER E, TALAMINI R, BERRETTA M, TIRELLI U. Comment on 'Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection'. Br J Cancer 2012; 106: 1899-1900.
26. NUNNARI G, SMITH JA, DANIEL R. HIV-1 Tat and AIDSassociated cancer: targeting the cellular anti-cancer barrier. J Exp Clin Cancer Res 2008; 27: 3.
27. CACOPARDO B, CAMMA C, PETTA S, PINZONE MR, CAPPELLANI A, ZANGHI A, NICOLOSI A, NUNNARI G. Diagnostic and therapeutical role of vitamin D in chronic hepatitis C virus infection. Front Biosci (Elite Ed. 2012 Jan 1;4:1276-86. Review. PubMed mPMID: 22201953.
28. APPAY V, SAUCE D. Immune activation and inflammation in HIV-1 infection: causes and consequences. J Pathol 2008; 214: 231-241.
29. NIXON DE, LANDAY AL. Biomarkers of immune dysfunction in HIV. Curr Opin HIV AIDS 2010; 5: 498-503.
30. PINZONE MR, DI ROSA M, CACOPARDO B, NUNNARI G. HIV RNA suppression and immune restoration: can we do better? Clin Dev Immunol 2012; 2012: 515962.
31. DI ROSA M, MALAGUARNERA L, NICOLOSI A, SANFILIPPO C, MAZZARINO C, PAVONE P, BERRETTA M, COSENTINO S, CACOPARDO B, PINZONE MR, NUNNARI G. Vitamin D3: an ever green molecule. Front Biosci (Schol Ed) 2013; 5: 247-260.
32. DI ROSA M, MALAGUARNERA G, DE GREGORIO C, PALUMBO M, NUNNARI G, MALAGUARNERA L. Immuno-modulatory effects of vitamin D3 in human monocyte and macrophages. Cell Immunol 2012; 280: 36-43.
33. GUILLOT X, SEMERANO L, SAIDENBERG-KERMANACH N, FALGARONE G, BOISSIER MC. Vitamin D and inflammation. Joint Bone Spine 2010; 77: 552-557.
34. HELMING L, BOSE J, EHRCHEN J, SCHIEBE S, FRAHM T, GEFFERS R, PROBST-KEPPER M, BALLING R, LENGELING A. Alpha, 25-dihydroxyvitamin D3 is a potent suppressor of interferon gamma-mediated macrophage activation. Blood 2005; 106: 4351-4358.
35. AMER M, QAYYUM R. Relation between serum 25- hydroxyvitamin D and C-reactive protein in asymptomatic adults (from the continuous national health and nutrition examination survey 2001 to 2006. Am J Cardiol 2012; 109: 226-230.
36. DAO CN, PATEL P, OVERTON ET, RHAME F, PALS SL, JOHNSON C, BUSH T, BROOKS JT; STUDY TO UNDERSTAND THE NATURAL HISTORY OF HIV AND AIDS IN THE ERA OF EFFECTIVE THERAPY (SUN INVESTIGATORS. Low vitamin D among HIV-infected adults: prevalence of and risk factors for low vitamin D Levels in a cohort of HIV-infected adults and comparison to prevalence among adults in the US general population. Clin Infect Dis 2011; 52: 396-405.
37. VIARD JP, SOUBERBIELLE JC, KIRK O, REEKIE J, KNYSZ B, LOSSO M, GATELL J, PEDERSEN C, BOGNER JR, LUNDGREN JD, MOCROFT A; EUROSIDA STUDY GROUP. Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study. AIDS 2011; 25: 1305-1315.
38. VESCINI F, COZZI-LEPRI A, BORDERI M, RE MC, MAGGIOLO F, DE LUCA A, CASSOLA G, VULLO V, CAROSI G, ANTINORI A, TOZZI V, MONFORTE AD; ICONA FOUNDATION STUDY GROUP. Prevalence of Hypovitaminosis D and Factors Associated With Vitamin D Deficiency and Morbidity Among HIV-Infected Patients Enrolled in a Large Italian Cohort. J Acquir Immune Defic Syndr 2011; 58: 163-172.
39. PINZONE MR, DI ROSA M, MALAGUARNERA M, MADEDDU G, FOCÀ E, CECCARELLI G, D'ETTORRE G, VULLO V, FISICHELLA R, CACOPARDO B, NUNNARI G. Vitamin D deficiency in HIV infection: an underestimated and undertreated epidemic. Eur Rev Med Pharmacol Sci 2013; 17: 1218-1232.
40. NUNNARI G, COCO C, PINZONE MR, PAVONE P, BERRETTA M, DI ROSA M, SCHNELL M, CALABRESE G, CACOPARDO B. The role of micronutrients in the diet of HIV- 1-infected individuals. Front Biosci (Elite Ed 2012; 4: 2442-2456.
41. MADEDDU G, SPANU A, SOLINAS P, CALIA GM, LOVIGU C, CHESSA F, MANNAZZU M, FALCHI A, MURA MS, MADEDDU G. Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy. Q J Nucl Med Mol Imaging 2004; 48: 39-48.
42. STEIN EM, YIN MT, MCMAHON DJ, SHU A, ZHANG CA, FERRIS DC, COLON I, DOBKIN JF, HAMMER SM, SHANE E. Vitamin D deficiency in HIV-infected postmenopausal Hispanic and African-American women. Osteoporos Int 2010; 22: 477-487.
43. CHOI AI, LO JC, MULLIGAN K, SCHNELL A, KALAPUS SC, LI Y, HUNT PW, MARTIN JN, DEEKS SG, HSUE PY. Association of vitamin D insufficiency with carotid intima- media thickness in HIV-infected persons. Clin Infect Dis 2011; 52: 941-944.
44. SZEP Z, GUARALDI G, SHAH SS, LO RE V 3RD, RATCLIFFE SJ, ORLANDO G, CARLI F, ROSSI R, ROCHIRA V, TEBAS P. Vitamin D deficiency is associated with type 2 diabetes mellitus in HIV infection. AIDS 2011; 25: 525-529.
45. LAI H, GERSTENBLITH G, FISHMAN EK, BRINKER J, KICKLER T, TONG W, BHATIA S, HONG T, CHEN S, LI J, DETRICK B, LAI S. Vitamin D deficiency is associated with silent coronary artery disease in cardiovascularly asymptomatic African Americans with HIV infection. Clin Infect Dis 2012; 54: 1747-1755.
46. HOLLIS BW. Comparison of commercially available (125Ibased RIA methods for the determination of circulating 25-hydroxyvitamin D. Clin Chem 2000; 46: 1657-1661.
47. EUROPEAN AIDS CLINICAL SOCIETY. Guidelines: prevention and management of non-infectious comorbidities in HIV. Available at http: //www. europeanaidsclinicalsociety. org/images/stories/EACSPdf/ EacsGuidelines-v6. 12edition.pdf. Accessed January 2013.
48. VAN DEN BOUT-VAN DEN BEUKEL CJ, FIEVEZ L, MICHELS M, SWEEP FC, HERMUS AR, BOSCH ME, BURGER DM, BRAVENBOER B, KOOPMANS PP, VAN DER VEN AJ. Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: effects of antiretroviral therapy. AIDS Res Hum Retroviruses 2008; 24: 1375-1382.
49. COZZOLINO M, VIDAL M, ARCIDIACONO MV, TEBAS P, YARASHESKI KE, DUSSO AS. HIV protease inhibitors impair vitamin D bioactivation to 1,25-dihydroxyvitamin D. AIDS 2003; 17: 513-520.
50. BROWN T, MC COMSEY G. Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D. Antivir Ther 2010; 15: 425-429.
51. WELZ T, CHILDS K, IBRAHIM F, POULTON M, TAYLOR CB, MONIZ CF, POST FA. Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase. AIDS 2010; 24: 1923-1928.
52. FUX CA, BAUMANN S, FURRER H, MUELLER NJ. Is lower serum 25-hydroxy vitamin D associated with efavirenz or the non-nucleoside reverse transcriptase inhibitor class? AIDS 2011; 25: 876-878.
53. HAUG CJ, AUKRUST P, HAUG E, MORKRID L, MULLER F, FROLAND SS. Severe deficiency of 1,25-dihydroxyvitamin D3 in human immunodeficiency virus infection: association with immunologic hyperactivity and only minor changes in calcium homeostasis. J Clin Endocrinol Metab 1998; 83: 3832- 3838.
54. CHILDS KE, FISHMAN SL, CONSTABLE C, GUTIERREZ JA, WYATT CM, DIETERICH DT, MULLEN MP, BRANCH AD. Short communication: inadequate vitamin D exacerbates parathyroid hormone elevations in tenofovir users. AIDS Res Hum Retroviruses 2010; 26: 855-899.
55. LABARGA P, BARREIRO P, MARTIN-CARBONERO L, ALVAREZ E, SOLERA C, PINILLA J. Prevalence and mechanisms of hyperparathyroidism in HIV+ patients treated with TDF. Abstr 18th Conference on Retroviruses and Opportunistic Infections Boston, MA, 2011.
56. MUELLER NJ, FUX CA, LEDERGERBER B, ELZI L, SCHMID P, DANG T, MAGENTA L, CALMY A, VERGOPOULOS A, BISCHOFF-FERRARI HA; SWISS HIV COHORT STUDY. High prevalence of severe vitamin D deficiency in combined antiretroviral therapy naive and successfully treated Swiss HIV patients. AIDS 2010; 24: 1127-1134.
57. MEHTA S, MUGUSI FM, SPIEGELMAN D, VILLAMOR E, FINKELSTEIN JL, HERTZMARK E, GIOVANNUCCI EL, MSAMANGA GI, FAWZI WW. Vitamin D status and its association with morbidity including wasting and opportunistic illnesses in HIV-infected women in Tanzania. AIDS Patient Care STDS 2011; 25: 579-585.
58. RIMANIOL AC, ZYLBERBERG H, ZAVALA F, VIARD JP. Inflammatory cytokines and inhibitors in HIV infection: Correlation between interleukin-1 receptor antagonist and weight loss. AIDS 1996; 10: 1349- 1356.
59. GODFRIED MH, VAN DER POLL T, JANSEN J, ROMIJIN JA, SCHATTENKERK JK, ENDERT E, VAN DEVENTER SJ, SAUERWEIN HP. Soluble receptors for tumour necrosis factor: A putative marker of disease progression in HIV infection. AIDS 1993; 7: 33-36.
60. POUDEL -TANDUKAR K, POUDEL KC, J IMBA M, KOBAYASHI J, JOHNSON CA, PALMER PH. Serum 25- hydroxyvitamin D levels and C-Reactive Protein in persons with human immunodeficiency virus infection. AIDS Res Hum Retroviruses 2013; 29: 528-534.
61. ANSEMANT T, MAHY S, PIROTH C, ORNETTI P, EWING S, GUILLAND JC, CROISIER D, DUVILLARD L, CHAVANET P, MAILLEFERT JF, PIROTH L. Severe hypovitaminosis D correlates with increased inflammatory markers in HIV infected patients. BMC Infect Dis 2013; 13: 7.
62. LIU PT, STENGER S, LI H, WENZEL L, TAN BH, KRUTZIK SR, OCHOA MT, SCHAUBER J, WU K, MEINKEN C, KAMEN DL, WAGNER M, BALS R, STEINMEYER A, ZÜGEL U, GALLO RL, EISENBERG D, HEWISON M, HOLLIS BW, ADAMS JS, BLOOM BR, MODLIN RL. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311(57968): 1770-1773.
63. STOFFELS K, OVERBERGH L, GIULIETTI A, VERLINDEN L, BOUILLON R, MATHIEU C. Immune Regulation of 25- Hydroxyvitamin-D3-1alpha-Hydroxylase in Human Monocytes. J Bone Miner Res 2006; 21: 37- 47.
64. BEARDEN A, ABAD C, GANGNON R, SOSMAN JM, BINKLEY N, SAFDAR N. Cross-sectional study of Vitamin D levels, immunologic and virologic outcomes in HIV-infected adults. J Clin Endocrinol Metab 2013; 98: 1726-1733.
65. DI BENEDETTO F, DE RUVO N, BERRETTA M, MASETTI M, MONTALTI R, DI SANDRO S, QUINTINI C, TIRELLI U, GERUNDA G. Don't deny Liver transplantation to HIV-positive patients with HCC in the HAARTera. JCO 2006; 24: e26-27.
66. DI BENEDETTO F, DI SANDRO S, DE RUVO N, BERRETTA M, MONTALTI R, GUERINI GP, BALLARIN R, DE BLASIIS MG, SPAGGIARI M, SMERIERI N, IEMMOLO RM, GUARALDI G, Gerunda GE Human immunodeficiency virus and liver transplantation: our point of view: Transplant Proc 2008; 40: 1965-1971.
67. BERRETTA M, ZANET E, DI BENEDETTO F, SIMONELLI C, BEARZ A, MORRA A, BONANNO S, BERRETTA S, TIRELLI U. Unusual presentation of metastatic hepatocellular carcinoma in an HIV/HCV coinfected patient: case report and review of the literature. Tumori 2008; 94: 589-591.
68. SIMONELLI C, TEDESCHI R, GLOGHINI A, TALAMINI R, BORTOLIN MT, BERRETTA M, SPINA M, MORASSUT A, VACCHER E, DE PAOLI P, CARBONE A, TIRELLI U. Plasma HHV-8 viral load in HHV-8 related lymphoproliferative disorders associated with HIV infection. J Med Virol 2009 24; 81: 888-896.
69. BERRETTA M, DI BENEDETTO F, BEARZ A, SIMONELLI C, BERRETTA S, SPINA M, TIRELLI U. Folfox-4 regimen with concomitant highly active antiretroviral therapy in metastatic colorectal cancer HIV-infected patients: a report of five cases and review of the literature. Cancer Invest 2008; 26: 610-614.
70. BERRETTA M, ZANET E, TAIBI R, MARTELLOTTA F, PAVONE P, BEARZ A, GOBITTI C, CIANCIA E.M, CANZONIERI V, TIRELLI U. Leiomyosarcoma of the parotid gland in a HIV-positive patient: therapeutic approach, clinical course and review of the literature. J Chemother 2009; 21: 215-218.
71. TAVIO M, GROSSI P, BACCARANI U, SCUDELLER L, PEA F, BERRETTA M, ADANI G, VIVARELLI M, RIVA A, TIRELLI U, BRESADOLA V, VIALE P. Risaliti A HIV-infected patients and liver transplantation: who, when and why. Curr HIV Res 2011; 9: 120-127.
72. MARTELLOTTA F, BERRETTA M, VACCHER E, SCHIOPPA O, ZANET E, TIRELLI U. AIDS-related Kaposi's sarcoma: state of art. Curr HIV Res 2009; 7: 634-638.